Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-25T16:32:19.750Z Has data issue: false hasContentIssue false
  • English
  • Français

Regulatory Issues on Behavioral and Psychological Symptoms of Dementia in the United States

Published online by Cambridge University Press:  10 January 2005

Thomas Laughren
Thomas Laughren
Affiliation:
Psychiatric Drug Products Group, Division of Neuropharmacological Drug Products, Food and Drug Administration, Rockville, Maryland, USA.
Get access

Extract

The entity, behavioral and psychological symptoms of dementia (BPSD), is a useful concept in that it focuses attention on an aspect of dementia that has long been ignored in both research and treatment. Although it is useful as a broad category that includes a number of more specific clinical entities, BPSD is too broad a target to serve as an indication for a particular drug. Labeling with such a claim would be potentially misleading because it would not be clear what specific patient population would likely benefit from treatment.

Type
Regulatory Issues
Information
International Psychogeriatrics , Volume 12 , Issue S1 , July 2000 , pp. 331 - 336
Copyright
© 2000 International Psychogeriatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)